ES2017596T3 - Un nuevo proceso para intermediarios de carbapen. - Google Patents

Un nuevo proceso para intermediarios de carbapen.

Info

Publication number
ES2017596T3
ES2017596T3 ES89104433T ES89104433T ES2017596T3 ES 2017596 T3 ES2017596 T3 ES 2017596T3 ES 89104433 T ES89104433 T ES 89104433T ES 89104433 T ES89104433 T ES 89104433T ES 2017596 T3 ES2017596 T3 ES 2017596T3
Authority
ES
Spain
Prior art keywords
alkyl
beta
carbapen
intermediaries
leaving group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89104433T
Other languages
English (en)
Other versions
ES2017596A4 (es
Inventor
Shoichiro Uyeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of ES2017596A4 publication Critical patent/ES2017596A4/es
Application granted granted Critical
Publication of ES2017596T3 publication Critical patent/ES2017596T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Automobile Manufacture Line, Endless Track Vehicle, Trailer (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN NUEVO INTERMEDIARIO PARA SINTETIZAR 4 (BETA) - (1(BETA) - ALQUIL - 2 - CARBOXIPROP - 2 - ENIL) - ACITIDIM - 2 - UNO (II), ES PREPARADO ESTEROSELECTIVAMENTE MEDIANTE EL TRATAMIENTO DE 4 - (GRUPO SALIENTE SUBSTITUIDO) ACETIM - E - UNO (I) CON TRANS - 2 - (GRUPO SALIENTE SUBSTITUIDO) METIL - 3 - ACIDO ALQUILACRILICO (III) Y UN METAL DE REDUCCION (FORMULA II); DONDE R1 ES HIDROGENO, ALQUIL O ALQUIL SUBSTITUIDO; R2 ALQUIL OPCIONALMENTE SUBSTITUIDO; R3 ES HIDROGENO O UN GRUPO PROTECTOR DE CARBOXI; Y R4 Y R5 CADA UNO ES UN GRUPO SALIENTE.
ES89104433T 1988-03-23 1989-03-13 Un nuevo proceso para intermediarios de carbapen. Expired - Lifetime ES2017596T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7076388 1988-03-23

Publications (2)

Publication Number Publication Date
ES2017596A4 ES2017596A4 (es) 1991-03-01
ES2017596T3 true ES2017596T3 (es) 1994-10-16

Family

ID=13440875

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89104433T Expired - Lifetime ES2017596T3 (es) 1988-03-23 1989-03-13 Un nuevo proceso para intermediarios de carbapen.

Country Status (9)

Country Link
US (1) US4960879A (es)
EP (1) EP0336143B1 (es)
KR (1) KR0125932B1 (es)
AT (1) ATE90343T1 (es)
AU (1) AU613724B2 (es)
CA (1) CA1340115C (es)
DE (1) DE68906945T2 (es)
ES (1) ES2017596T3 (es)
GB (1) GB2216525B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0308867B1 (en) * 1987-09-22 1995-07-26 Shionogi Seiyaku Kabushiki Kaisha Alkenylsilylazetidinone intermediates for carbapenems
CA2000565C (en) * 1988-10-19 1998-06-23 Masaji Ishiguro Process for the preparation of 4-acyloxy-2-azetidinone derivatives
US4992545A (en) * 1989-09-20 1991-02-12 Eli Lilly And Company Process for preparing 4-substituted azetidinones
JPH03120280A (ja) * 1989-10-03 1991-05-22 Shionogi & Co Ltd ハロメチルカルバペネム化合物の製法
FI96311C (fi) * 1989-12-04 1996-06-10 Squibb Bristol Myers Co Menetelmä farmaseuttisesti käyttökelpoisten 6-(1-hydroksietyyli)-3-(substituoitu tio)-7-okso-1-atsabisyklo/3.2.0/hept-2-eeni-2-karboksyylihappojohdannaisten valmistamiseksi
US5672701A (en) * 1990-01-16 1997-09-30 Bristol-Myers Squibb Company 4-substituted alkyl carbapenem antibiotics
US5068232A (en) * 1990-04-10 1991-11-26 American Cyanamid Company Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
US6216687B1 (en) 1996-03-22 2001-04-17 The Majestic Products Company Unvented heating appliance having system for reducing undesirable combustion products
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
AU722405B2 (en) * 1997-01-21 2000-08-03 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
US6346617B1 (en) 1997-08-26 2002-02-12 Merck & Co., Inc. Crystalline 2-hydroxymethyl carbapenem intermediate compounds and process for synthesis thereof
JP2001514169A (ja) * 1997-08-27 2001-09-11 メルク エンド カムパニー インコーポレーテッド β−メチルカルバペネム中間体の製造
US6143885A (en) * 1997-08-27 2000-11-07 Merck & Co., Inc. Preparation of beta-methyl carbapenem intermediates
US7632828B2 (en) * 2004-06-10 2009-12-15 Fob Synthesis, Inc. Gram-positive carbapenem antibacterials and processes for their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE10838T1 (de) * 1980-02-28 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.
JPS60158167A (ja) 1984-01-27 1985-08-19 Sumitomo Chem Co Ltd β−ラクタム化合物の製造法
EP0180189B1 (en) * 1984-10-31 1991-01-23 Sumitomo Pharmaceuticals Company, Limited Novel beta-lactams and their production
DE3509769A1 (de) * 1985-03-19 1986-09-25 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von carbapenemzwischenprodukten
JPS6229577A (ja) 1985-07-31 1987-02-07 Sumitomo Pharmaceut Co Ltd オキサゾリジン誘導体
JPS62103063A (ja) * 1985-10-29 1987-05-13 Sagami Chem Res Center アゼチジノン誘導体の製造方法

Also Published As

Publication number Publication date
GB2216525A (en) 1989-10-11
GB2216525B (en) 1992-01-02
US4960879A (en) 1990-10-02
AU613724B2 (en) 1991-08-08
DE68906945D1 (de) 1993-07-15
ATE90343T1 (de) 1993-06-15
EP0336143B1 (en) 1993-06-09
CA1340115C (en) 1998-11-03
KR0125932B1 (ko) 1997-12-26
ES2017596A4 (es) 1991-03-01
KR890014470A (ko) 1989-10-23
DE68906945T2 (de) 1993-10-14
EP0336143A1 (en) 1989-10-11
GB8906597D0 (en) 1989-05-04
AU3159989A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
ES2017596T3 (es) Un nuevo proceso para intermediarios de carbapen.
TW221285B (es)
NO991019D0 (no) 3-merkapto-1-(1,3-tiazolin-2-yl)azetidin-derivater
DE69026851D1 (de) Verfahren zur Erhöhung von Chemilumineszenz
GR3036070T3 (en) New process for the production of cephalosporines and novel intermediates in this process.
AU8230891A (en) Novel benzopyran derivative
PT92609A (pt) Processo para a preparacao de derivados 4,5,6,7-tetrahidroben zimidazoles
ES2145920T3 (es) Procedimiento de produccion de derivado de alcoxiiminoacetamida.
HUT37444A (en) Process for preparing bestatin derivatives
HU9203677D0 (en) Method for producing 2-carboxi-carbapeneme and 2-carboxi-carbacephene derivatives
BR9405302A (pt) Processo para a preparação de um composto e o referido composto
HU904946D0 (en) Process for producing new imidazole derivatives
BR8502884A (pt) Derivado de azetidina e processo para preparar acido azetidino-3-carboxilico
KR0137673B1 (en) Process for preparing sulfonamide derivative of norbornane
ATE234927T1 (de) Clavulansäure-dehydrogenase, herstellung und verwendung für die herstellung von clavulansäure
HUT48258A (en) Process for producing macrolid compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 336143

Country of ref document: ES